Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

GlaxoSmithKline completed a Phase 2 trial evaluating the safety, tolerability, and immune response of the AFX3772 vaccine in healthy infants. The study targeted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection
• Pneumonia

Drugs mentioned

• AFX3772 vaccine (AFX3772)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pneumonia, Bacterial, Pneumococcal Infections | Phase 2 | Status: COMPLETED